top of page
Find Out More
Via Phone:
Via Email:

Covid-19 Response Products

Patient Management

Patient Management  /  Lateral flow flurescence-based immunoassay  /  RAMP PCT


Lateral flow flurescence-based immunoassay

Response Biomedical
Product Cat:
Class C. MDA Approved
*Professional Use Only 

Procalcitonin (PCT) is a sensitive biomarker that is increased in the blood of sepsis patients. PCT is used by doctors to differentiate between bacterial sepsis and other conditions that have similar symptoms.

  • RAMP Procalcitonin is a quantitative in vitro diagnostic test used with the RAMP System to measure levels of the prohormone procalcitonin (PCT) directly from a small sample of whole blood preserved in EDTA.

  • In acute care testing, the RAMP System will help clinician to make informed patient management decisions. It is the only fast, quantitative, and self-calibrating platform and iit provides accurate results. With the RAMP 200 and RAMP reader systems, you'll get faster results with less stress in the lab.

  • *Designed to be run with RAMP System

  • **Quality control is optional

Features and Benefits:

  • RAMP® System is a lateral flow immunoassay platform that provides accurate and precise diagnostic information in ~15 minutes. Every package includes a calibrated transfer device, as well as a patented RAMP® buffer that improves performance.

  • Together with a quantitative fluorescence immunoassay principle, the RAMP ratio enables adjustment for sources of analytical variability.

  • Only 75 µL of EDTA whole blood is required. The test can be performed in about 15 minutes.

  • A single-use test cartridge with a barcode is used to calibrate a specific lot.

  • 12-month shelf life.

Click Here for more product information on our partner site
Related Products:
Lateral flow flurescence-based immunoassay
Response Biomedical
Lateral flow flurescence-based immunoassay
Response Biomedical
bottom of page